DTA-H19

· Hebrew University of Jerusalem

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DTA-H19, covering 2008-01-07 to 2019-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer [Phase 1, Phase 2]